A Prospective Study to Evaluate the Outcome of Periarthritis Shoulder Treated with Platelet Rich Plasma

Background: Periarthritis shoulder also called as Adhesive capsulitis or Frozen shoulder. In the general population, the prevalence of adhesive capsulitis is 3 -55%, and it is 20% in those with diabetes. Many types of treatment have been employed in the treatment of shoulder disorder such as simple analgesia, NSAIDS, intraarticular steroid, platelet rich plasma injection & surgery. Although this condition is associated with a number of risk factors, including female sex, trauma, age more than 40, thyroid disease, stroke, myocardial infarction, extended mobility and the existence off an autoimmune disease, the pathophysiology of this disorder is yet unknown. PRP has a low risk of immunological responses and the spread of infectious and dangerous diseases since it is an autologous biologic substance. It is vital to examine the use of PRP and evaluate its effectiveness in comparison to steroid injections given the backdrop of conflicting data for treatment modalities and the new introduction of PRP as a biological agent encouraging healing.